Patent · US Active

Anti-TAT 113 antibodies

US7547768B2 · kind B2 · utility

8Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 20, 2007
Grant dateJun 16, 2009
Priority date
Expiry dateNov 20, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.